Targeting EPHB2/ABL1 restores anti-tumor immunity in a preclinical model of ependymoma

被引：0
|
作者：
Ren, Jun
Amoozgar, Zohreh
Zhao, Yuhui
Lei, Pinji
Ho, William W.
Robergea, Sylvie
Huang, Peigen
Duda, Dan G.
Xu, Lei
Jain, Rakesh K.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2343
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2343
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Inhibition of A2AR induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical and clinical studies
    Willingham, Stephen
    Hotson, Andrew
    Ho, Po
    Choy, Carmen
    Walter, Kim
    Yusko, Erik
    Benzeno, Sharon
    Laport, Ginna
    Miller, Richard
    McCaffery, Ian
    CANCER RESEARCH, 2017, 77
  • [22] A new murine tumor model for studying HLA-A2-restrieted anti-tumor immunity
    Kaplan, BLF
    Moore, TV
    Schreiber, K
    Callender, GG
    Schreiber, H
    Nishimura, MI
    CANCER LETTERS, 2005, 224 (01) : 153 - 166
  • [23] Oral administration of Manuka honey leads to enhanced anti-tumor immunity in a syngeneic preclinical model of colorectal cancer
    Masad, R. J.
    Lootah, S.
    Mohamed, Y. A.
    Bashir, G.
    Amer, R.
    Alsbiei, A.
    Fernandez-Cabezudo, M. J.
    Al Ramadi, B. K.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1905 - 1905
  • [24] Targeting TBL1 with tegavivint promotes anti-tumor and immunomodulatory responses in preclinical models of hepatocellular carcinoma
    Holloway, Kimberly R.
    Drake, Thomas
    Bird, Thomas
    Horrigan, Stephen
    CANCER RESEARCH, 2023, 83 (07)
  • [25] MAP4K1 inhibition enhances immune cell activation and anti-tumor immunity in preclinical tumor models.
    Faia, Kerrie
    Toso, Alberto
    Fetalvero, Kristina
    Roche, Marly
    Bench, Steven
    O'Hearn, Erin
    Cao, Qiongfang
    Bright, Kerry-Ann
    Paduraru, Debora
    Romagnani, Andrea
    Weng, Weifan
    Zimmermann, Tina
    Burke, Michael
    Close, Joshua
    Green, Luke
    Kim, Joseph
    Miduturu, Chandra
    Ribeiro, Alison
    Bacac, Marina
    Herter, Sylvia
    Perola, Emanuele
    Sheets, Michael
    Eckmann, Jan
    Heidkamp, Gordon
    Traore, Tary
    Gerson, Erik
    Woessner, Rich
    Wolter, Carsten
    Scheuplein, Felix
    Perez, Nisha
    LaBranche, Timothy
    Silva, Grace
    Ye, Chaoyang
    Utt, Caitlin
    Gross, Stefan
    Bischoff, James R.
    Dorsch, Marion
    Guzi, Tim
    Hoeflich, Klaus
    Brubaker, Jason
    CANCER RESEARCH, 2021, 81 (13)
  • [26] Targeting NPC1L1 rescues anti-tumor immunity and improves immunotherapeutic efficacy in pancreatic cancer
    Liang, H.
    Ou, J.
    Chen, Z.
    Zi, R.
    Shen, K.
    Zheng, P.
    Su, X.
    ANNALS OF ONCOLOGY, 2023, 34 : S912 - S913
  • [27] ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
    Wu, Youqian
    Zhang, Chao
    Liu, Xiaolan
    He, Zhengfu
    Shan, Bing
    Zeng, Qingxin
    Zhao, Qingwei
    Zhu, Huaying
    Liao, Hongwei
    Cen, Xufeng
    Xu, Xiaoyan
    Zhang, Mengmeng
    Hou, Tingjun
    Wang, Zhe
    Yan, Huanhuan
    Yang, Shuying
    Sun, Yaqin
    Chen, Yanying
    Wu, Ronghai
    Xie, Tingxue
    Chen, Wei
    Najafov, Ayaz
    Ying, Songmin
    Xia, Hongguang
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [28] ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
    Youqian Wu
    Chao Zhang
    Xiaolan Liu
    Zhengfu He
    Bing Shan
    Qingxin Zeng
    Qingwei Zhao
    Huaying Zhu
    Hongwei Liao
    Xufeng Cen
    Xiaoyan Xu
    Mengmeng Zhang
    Tingjun Hou
    Zhe Wang
    Huanhuan Yan
    Shuying Yang
    Yaqin Sun
    Yanying Chen
    Ronghai Wu
    Tingxue Xie
    Wei Chen
    Ayaz Najafov
    Songmin Ying
    Hongguang Xia
    Nature Communications, 12
  • [29] Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation
    Shi, Chengyu
    Wang, Ying
    Wu, Minjie
    Chen, Yu
    Liu, Fangzhou
    Shen, Zheyuan
    Wang, Yiran
    Xie, Shaofang
    Shen, Yingying
    Sang, Lingjie
    Zhang, Zhen
    Gao, Zerui
    Yang, Luojia
    Qu, Lei
    Yang, Zuozhen
    He, Xinyu
    Guo, Yu
    Pan, Chenghao
    Che, Jinxin
    Ju, Huaiqiang
    Liu, Jian
    Cai, Zhijian
    Yan, Qingfeng
    Yu, Luyang
    Wang, Liangjing
    Dong, Xiaowu
    Xu, Pinglong
    Shao, Jianzhong
    Liu, Yang
    Li, Xu
    Wang, Wenqi
    Zhou, Ruhong
    Zhou, Tianhua
    Lin, Aifu
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [30] Blocking the FSTL1-DIP2A Axis Improves Anti-tumor Immunity
    Kudo-Saito, Chie
    Ishida, Akiko
    Shouya, Yuji
    Teramoto, Koji
    Igarashi, Tomoyuki
    Kon, Ryoko
    Saito, Kenji
    Awada, Chihiro
    Ogiwara, Yamato
    Toyoura, Masayoshi
    CELL REPORTS, 2018, 24 (07): : 1790 - 1801
12345